Effect of ritanserin and leuprolide alone and combined on marble-burying behavior of mice

Acta Poloniae Pharmaceutica - Drug Research

Volumn 67, Issue 5, 2010, Pages 523-527

  Gaikwad, Uday ^a   Parle, Milind ^a   Kumar, Ashok ^a   Gaikwad, Dinanath ^b  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b Government College of Pharmacy   (India)

Author keywords

Leuprolide; Marble burying behavior; Motor activity; Ritanserin

Indexed keywords

LEUPRORELIN; RITANSERIN; GONADORELIN; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; COMPULSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; AGONISTS; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; OBSESSIVE-COMPULSIVE DISORDER;

ANIMALS; BEHAVIOR, ANIMAL; GONADOTROPIN-RELEASING HORMONE; LEUPROLIDE; MALE; MICE; MOTOR ACTIVITY; OBSESSIVE-COMPULSIVE DISORDER; RITANSERIN; SEROTONIN ANTAGONISTS;

EID: 77956376277     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Schwartz J.M.: J. Consciousness Stud. 6:115 (1999).
2. Rasmusen S.A., Eisen J.L.:Psychiatr. Clin, North Am. 15, 743 (1992).
3. Rasmussen S.A., Eisen J.L.: Psychiatr. Ann. 9, 67 (1989).
4. Stein D.J: Biol. Psychiatry 47, 296 (2000).
5. Joel D., Avisar A.: Behav. Brain Res. 123, 77 (2001).
6. Szechtman H, Sulis W, Eilam D.: Behav. Neurosci. 112, 1475 (1998).
7. Archer T., Fredriksson A., Lewander T., Soderberg U. S.: J. Psychol. 28, 242 (1987).
8. Treit D.: Pharmacol. Biochem. Behav. 36, 203 (1990).
9. Wilkie D.M., MacLennan A.J., Pinel J.P.: J. Exp. Anal. Behav. 31, 99 (1979).
10. Londei T., Valentini A.M., Leone V.G.: Behav. Brain Res. 94, 249 (1998).
11. Njung'e K., Handley S.L.: Biochem. Behav. 38, 63 (1991).
12. Parle M., Gaikwad U.: Int. J. Med. Sci. 2, 84 (2009).
13. Sasson Y., Zohar J., Chopra M., Lustig M., Iancu I., Hendler T.: J. Clin. Psychiat. 58, 7 (1997).
14. Parle M., Gaikwad U.: Asian J. BioSci. 4, 120 (2009).
15. Poling A., Cleary J., Monaghan M.: J. Exp. Anal. Behav. 35, 31 (1981).
16. Rapoport J.L.: J. Am. Med. Assoc. 260, 2888 (1988).
17. Billett E.A., Richter M.A., King N.: Mol. Psychiat. 2, 403 (1997).
18. Martin J.R., Bos M., Jenck F., Moreau J., Mutel V. et al.: J. Pharmacol. Exp. Ther. 286, 913 (1998).
19. Millan M.J., Dekeyne A., Papp M., La Rochelle C.D., MacSweeny C. et al.: J. Pharmacol. Exp. Ther. 298, 581 (2001).
20. Ichimaru Y., Egawa T., Sawa A.: Jpn. J. Pharmacol. 68, 65 (1995).
21. Gyertyan I.: Behav. Pharmacol. 6, 24 (1995).
22. Broekkamp C.L., Rijk H.W., Joly-Gelouin D., Lloyd K.L.: Eur. J. Pharmacol. 126, 223 (1986).
23. Rance N.E., Young III W.S., McMullen N.T.: J. Comp. Neurol. 339, 573 (1994).
24. Johnson M.D., Crowley W.R.: Endocrinology 118, 1180 (1986).
25. Aouizerate B., Guehl D., Cuny E., Rougier A., Bioulac B., Tignol J., Burbaud P.: Prog. Neurobiol. 72, 195 (2004).
26. Pan J.T., Kow L.M., Pfaff D.W.: Neuroscience 27, 623 (1988).
27. Massol J.P., Patrick M., Adesci G., Puech A.J.: Eur. J. Pharmacol. 160, 395 (1989).
28. Jain M.R, Subhedar N.K.: Brain Res. 604, 7 (1993).
29. Eriksson, T.: Am. J. Psychiat. 157,483 (2000).
30. Kadar T., Telegdy G., Schally A.V.: Physiol. Behav. 51, 601 (1992).